Krsna Diagnostics Promoter Group Allotted Convertible Warrants via Preferential Basis
Krsnaa Diagnostics Ltd · Acquisition/ Disposal of Shares · 16 Oct 2026, 3:55 pm
Krsna Diagnostics Promoter Group Allotted Convertible Warrants via Preferential Basis Promoter group entities of Krsna Diagnostics Ltd, including Krsna Diagnostics (Mumbai) Pvt Ltd (15.46 lakh warrants) and Rajendra Mutha (0.75 lakh warrants), were allotted 16.21 lakh fully convertible warrants on 13th Oct'26. The preferential allotment was priced at ₹566 per warrant, with 25% received upfront. Post-allotment, the promoter and PAC holding stands at 87.96 lakh equity shares (27.11% voting capital; 25.08% diluted) and increases to 1.04 crore equity shares (29.70% of total diluted share capital) assuming full warrant conversion.
Original exchange filing (PDF)
More announcements from Krsnaa Diagnostics Ltd
- Earnings Call Transcript for quarter and half year ended September 30, 2026 · 08 Nov 2026
- Intimation of Change in Corporate office of Registrar and Sahre Trasnfer Agent of the Company w.e.f. 1st December 2026. · 04 Nov 2026
- Audio recording of conference call for the quarter and half year ended September 30, 2026 · 04 Nov 2026
- Submission of Certificate obtained from Statutory Auditors in terms of Regulation 169(5) of the SEBI ICDR Regulations, 2018 · 03 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Krsnaa Diagnostics secures 15 year Cash based PPP project from Municipal corporation of Delhi for Advanced CT Scan and .... · 03 Nov 2026
- Investor Presentation for the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026 · 03 Nov 2026
- Press Release - Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026 · 03 Nov 2026
- Financial Results for Quarter and Half Year ended September 30, 2026 · 02 Nov 2026
